Cargando…
Inhibition of Soluble Epoxide Hydrolase for Renal Health
A soluble epoxide hydrolase (sEH) mediates the metabolism of epoxy fatty acids to form the corresponding vicinal diols, which are usually inactive or less active than the epoxide substrates. The sEH enzyme presents in many organs, including but not limited to the liver, heart, spleen, lung, and kidn...
Autor principal: | Liu, Jun-Yan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6335332/ https://www.ncbi.nlm.nih.gov/pubmed/30687105 http://dx.doi.org/10.3389/fphar.2018.01551 |
Ejemplares similares
-
Pharmaceutical Effects of Inhibiting the Soluble Epoxide Hydrolase in Canine Osteoarthritis
por: McReynolds, Cindy B., et al.
Publicado: (2019) -
Soluble Epoxide Hydrolase Inhibition for Ocular Diseases: Vision for the Future
por: Park, Bomina, et al.
Publicado: (2019) -
Editorial: Clinical Paths for Soluble Epoxide Hydrolase Inhibitors
por: Imig, John D., et al.
Publicado: (2020) -
Soluble Epoxide Hydrolase Deletion Limits High-Fat Diet-Induced Inflammation
por: Wagner, Karen M., et al.
Publicado: (2021) -
Role of Soluble Epoxide Hydrolase in Metabolism of PUFAs in Psychiatric and Neurological Disorders
por: Hashimoto, Kenji
Publicado: (2019)